Ever Source Wealth Advisors, LLC Design Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 235 shares of DSGN stock, worth $1,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 31
658.06%
Holding current value
$1,370
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DSGN
# of Institutions
95Shares Held
33.5MCall Options Held
13KPut Options Held
0-
Sr One Capital Management, LP6.53MShares$38 Million7.89% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$24.6 Million1.83% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$13.4 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.95MShares$11.4 Million0.35% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.81MShares$10.5 Million0.01% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $325M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...